EED and cancer: Notably, less resistancewas observed during 43c treatment of Pfeiffer and KARPAS422DLBCL cell lines, therefore confirming that the PRC2 allosteric inhibitors(EED binders) could help to overcome the resistance induced by theEZH2 catalytic inhibitors in cancer therapy.